Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Human Fibrinogen
Revenue, means the sales value of Human Fibrinogen
This report studies Human Fibrinogen in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
CSL Behring
Baxter
Johnson & Johnson (Ethicon)
LFB Group
ProFibrix BV (The Medicines Company)
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Pure Human Fibrinogen
Fibrinogen Concentrate (Human)
Split by Application, this report focuses on consumption, market share and growth rate of Human Fibrinogen in each application, can be divided into
Congenital Fibrinogen Deficiency
Surgical Procedures
China Human Fibrinogen Market Research Report 2017
1 Human Fibrinogen Market Overview
1.1 Product Overview and Scope of Human Fibrinogen
1.2 Human Fibrinogen Segment by Type
1.2.1 China Production Market Share of Human Fibrinogen Type in 2015
1.2.2 Pure Human Fibrinogen
1.2.3 Fibrinogen Concentrate (Human)
1.3 Applications of Human Fibrinogen
1.3.1 Human Fibrinogen Consumption Market Share by Application in 2015
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 China Market Size (Value) of Human Fibrinogen (2011-2021)
1.5 China Human Fibrinogen Status and Outlook
1.6 Government Policies
2 China Human Fibrinogen Market Competition by Manufacturers
2.1 China Human Fibrinogen Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Human Fibrinogen Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Human Fibrinogen Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Human Fibrinogen Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Fibrinogen Market Competitive Situation and Trends
2.5.1 Human Fibrinogen Market Concentration Rate
2.5.2 Human Fibrinogen Market Share of Top 3 and Top 5 Manufacturers
3 China Human Fibrinogen Manufacturers Profiles/Analysis
3.1 CSL Behring
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Human Fibrinogen Product Type, Application and Specification
3.1.2.1 Pure Human Fibrinogen
3.1.2.2 Fibrinogen Concentrate (Human)
3.1.3 CSL Behring Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Baxter
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Human Fibrinogen Product Type, Application and Specification
3.2.2.1 Pure Human Fibrinogen
3.2.2.2 Fibrinogen Concentrate (Human)
3.2.3 Baxter 114 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Johnson & Johnson (Ethicon)
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Human Fibrinogen Product Type, Application and Specification
3.3.2.1 Pure Human Fibrinogen
3.3.2.2 Fibrinogen Concentrate (Human)
3.3.3 Johnson & Johnson (Ethicon) 118 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 LFB Group
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Human Fibrinogen Product Type, Application and Specification
3.4.2.1 Pure Human Fibrinogen
3.4.2.2 Fibrinogen Concentrate (Human)
3.4.3 LFB Group Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 ProFibrix BV (The Medicines Company)
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Human Fibrinogen Product Type, Application and Specification
3.5.2.1 Pure Human Fibrinogen
3.5.2.2 Fibrinogen Concentrate (Human)
3.5.3 ProFibrix BV (The Medicines Company) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Shanghai RAAS Blood Products
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Human Fibrinogen Product Type, Application and Specification
3.6.2.1 Pure Human Fibrinogen
3.6.2.2 Fibrinogen Concentrate (Human)
3.6.3 Shanghai RAAS Blood Products Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Jiangxi Boya Bio-Pharmaceutical
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Human Fibrinogen Product Type, Application and Specification
3.7.2.1 Pure Human Fibrinogen
3.7.2.2 Fibrinogen Concentrate (Human)
3.7.3 Jiangxi Boya Bio-Pharmaceutical Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Hualan Biological Engineering
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Human Fibrinogen Product Type, Application and Specification
3.8.2.1 Pure Human Fibrinogen
3.8.2.2 Fibrinogen Concentrate (Human)
3.8.3 Hualan Biological Engineering Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Harbin Pacific Biopharmaceutical
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Human Fibrinogen Product Type, Application and Specification
3.9.2.1 Pure Human Fibrinogen
3.9.2.2 Fibrinogen Concentrate (Human)
3.9.3 Harbin Pacific Biopharmaceutical Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Greencross
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Human Fibrinogen Product Type, Application and Specification
3.10.2.1 Pure Human Fibrinogen
3.10.2.2 Fibrinogen Concentrate (Human)
3.10.3 Greencross Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Shanghai XinXing Medical
4 China Human Fibrinogen Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
4.1 China Human Fibrinogen Capacity, Production and Growth (2011-2016)
4.2 China Human Fibrinogen Revenue and Growth (2011-2016)
4.3 China Human Fibrinogen Production, Consumption, Export and Import (2011-2016)
5 China Human Fibrinogen Production, Revenue (Value), Price Trend by Type
5.1 China Human Fibrinogen Production and Market Share by Type (2011-2016)
5.2 China Human Fibrinogen Revenue and Market Share by Type (2011-2016)
5.3 China Human Fibrinogen Price by Type (2011-2016)
5.4 China Human Fibrinogen Production Growth by Type (2011-2016)
6 China Human Fibrinogen Market Analysis by Application
6.1 China Human Fibrinogen Consumption and Market Share by Application (2011-2016)
6.2 China Human Fibrinogen Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaHuman Fibrinogen Market Analysis by Regions (Provinces)
7.1 China Human Fibrinogen Production, Production Value and Price by Regions (Provinces)(2011-2016)
7.1.1 China Human Fibrinogen Production and Market Share by Regions (Provinces)(2011-2016)
7.1.2 China Human Fibrinogen Production Value and Market Share by Regions (Provinces)(2011-2016)
7.1.3 China Human Fibrinogen Sales Price by Regions (Provinces)(2011-2016)
7.2 China Human Fibrinogen Consumption by Regions (Provinces)(2011-2016)
7.3 China Human Fibrinogen Production, Consumption, Export and Import (2011-2016)
8 Human Fibrinogen Manufacturing Cost Analysis
8.1 Human Fibrinogen Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Fibrinogen
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Fibrinogen Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Fibrinogen Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Human Fibrinogen Market Forecast (2016-2021)
12.1 China Human Fibrinogen Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Human Fibrinogen Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Human Fibrinogen Production Forecast by Type (2016-2021)
12.4 China Human Fibrinogen Consumption Forecast by Application (2016-2021)
12.5 China Human Fibrinogen Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.5.1 China Human Fibrinogen Production Forecast by Regions (Provinces)(2016-2021)
12.5.2 China Human Fibrinogen Consumption Forecast by Regions (Provinces)(2016-2021)
12.5.3 China Human Fibrinogen Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Human Fibrinogen Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Human Fibrinogen
Figure China Production Market Share of Human Fibrinogen by Type in 2015
Figure Product Picture of Pure Human Fibrinogen
Table Major Manufacturers of Pure Human Fibrinogen
Figure Product Picture of Fibrinogen Concentrate (Human)
Table Major Manufacturers of Fibrinogen Concentrate (Human)
Table Human Fibrinogen Consumption Market Share by Application in 2015
Figure Congenital Fibrinogen Deficiency Examples
Figure Surgical Procedures Examples
Figure China Human Fibrinogen Revenue (Million USD) and Growth Rate (2011-2021)
Table China Human Fibrinogen Capacity of Key Manufacturers (2015 and 2016)
Table China Human Fibrinogen Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Human Fibrinogen Capacity of Key Manufacturers in 2015
Figure China Human Fibrinogen Capacity of Key Manufacturers in 2016
Table China Human Fibrinogen Production of Key Manufacturers (2015 and 2016)
Table China Human Fibrinogen Production Share by Manufacturers (2015 and 2016)
Figure 2015 Human Fibrinogen Production Share by Manufacturers
Figure 2016 Human Fibrinogen Production Share by Manufacturers
Table China Human Fibrinogen Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Human Fibrinogen Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Human Fibrinogen Revenue Share by Manufacturers
Table 2016 China Human Fibrinogen Revenue Share by Manufacturers
Table China Market Human Fibrinogen Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Human Fibrinogen Average Price of Key Manufacturers in 2015
Table Manufacturers Human Fibrinogen Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Fibrinogen Product Type
Figure Human Fibrinogen Market Share of Top 3 Manufacturers
Figure Human Fibrinogen Market Share of Top 5 Manufacturers
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Behring Human Fibrinogen Market Share (2011-2016)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Fibrinogen Market Share (2011-2016)
Table Johnson & Johnson (Ethicon) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (Ethicon) Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson (Ethicon) Human Fibrinogen Market Share (2011-2016)
Table LFB Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LFB Group Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure LFB Group Human Fibrinogen Market Share (2011-2016)
Table ProFibrix BV (The Medicines Company) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProFibrix BV (The Medicines Company) Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure ProFibrix BV (The Medicines Company) Human Fibrinogen Market Share (2011-2016)
Table Shanghai RAAS Blood Products Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai RAAS Blood Products Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Shanghai RAAS Blood Products Human Fibrinogen Market Share (2011-2016)
Table Jiangxi Boya Bio-Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Market Share (2011-2016)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Biological Engineering Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hualan Biological Engineering Human Fibrinogen Market Share (2011-2016)
Table Harbin Pacific Biopharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Harbin Pacific Biopharmaceutical Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Harbin Pacific Biopharmaceutical Human Fibrinogen Market Share (2011-2016)
Table Greencross Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Greencross Human Fibrinogen Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Greencross Human Fibrinogen Market Share (2011-2016)
Table Shanghai XinXing Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Human Fibrinogen Capacity, Production and Growth (2011-2016)
Figure China Human Fibrinogen Revenue (Million USD) and Growth (2011-2016)
Table China Human Fibrinogen Production, Consumption, Export and Import (2011-2016)
Table China Human Fibrinogen Production by Type (2011-2016)
Table China Human Fibrinogen Production Share by Type (2011-2016)
Figure Production Market Share of Human Fibrinogen by Type (2011-2016)
Figure 2015 Production Market Share of Human Fibrinogen by Type
Table China Human Fibrinogen Revenue by Type (2011-2016)
Table China Human Fibrinogen Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Human Fibrinogen by Type (2011-2016)
Figure 2015 Revenue Market Share of Human Fibrinogen by Type
Table China Human Fibrinogen Price by Type (2011-2016)
Figure China Human Fibrinogen Production Growth by Type (2011-2016)
Table China Human Fibrinogen Consumption by Application (2011-2016)
Table China Human Fibrinogen Consumption Market Share by Application (2011-2016)
Figure China Human Fibrinogen Consumption Market Share by Application in 2015
Table China Human Fibrinogen Consumption Growth Rate by Application (2011-2016)
Figure China Human Fibrinogen Consumption Growth Rate by Application (2011-2016)
Table China Human Fibrinogen Production by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Production Market Share by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Production Value by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Sales Price by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Consumption by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Human Fibrinogen Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Fibrinogen
Figure Manufacturing Process Analysis of Human Fibrinogen
Figure Human Fibrinogen Industrial Chain Analysis
Table Raw Materials Sources of Human Fibrinogen Major Manufacturers in 2015
Table Major Buyers of Human Fibrinogen
Table Distributors/Traders List
Figure China Human Fibrinogen Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Human Fibrinogen Revenue and Growth Rate Forecast (2016-2021)
Table China Human Fibrinogen Production, Import, Export and Consumption Forecast (2016-2021)
Table China Human Fibrinogen Production Forecast by Type (2016-2021)
Table China Human Fibrinogen Consumption Forecast by Application (2016-2021)
Table China Human Fibrinogen Production Forecast by Regions (Provinces)(2016-2021)
Table China Human Fibrinogen Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Human Fibrinogen Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...